Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Twenty years of monkey research boosts AIDS knowledge

28.08.2002


Research on an AIDS-like disease in monkeys continues to help scientists understand problems such as how HIV causes AIDS, how the virus "hides" from the immune system and how the disease might be prevented or treated, two decades after the human and monkey diseases were identified.



"These animals have been indispensable for understanding how the virus works and in working toward vaccines," said Murray Gardner, professor emeritus of medical pathology at the UC Davis Center for Comparative Medicine.

About 300 researchers from around the world will reflect on those past achievements and discuss new data when they gather Sept. 8-11 in Monterey, Calif., for the 20th Annual Symposium on Nonhuman Primate Models for AIDS. The California National Primate Research Center (CNPRC) at the University of California, Davis, is hosting the conference.


More than 20 years ago, scientists at the UC Davis primate center were confronted with a mysterious and deadly outbreak of infections in their monkeys. Showing signs of weakened immune systems, the monkeys were succumbing to a variety of infections that normally did not cause disease.

At about the same time, a deadly new disease known as AIDS was making the headlines. Bearing a striking resemblance to the monkey syndrome, the human disease also led to opportunistic infections, wasting and death.

Scientists would later discover that the monkey disease, called simian AIDS, was caused by the simian immunodeficiency virus (SIV), a close relative of the human immunodeficiency virus (HIV) that causes human AIDS.

The striking similarities between the human and simian disorders and the viruses that cause them enabled scientists to gain otherwise unobtainable insights into the origins and progression of human AIDS -- work that continues today.

Today, scientists at the UC Davis center are using the SIV monkey model of AIDS to study ways to vaccinate against HIV transmission from adult to adult and from mother to offspring. They are also tackling the problem of eliminating latent virus -- virus that is inactive and "hiding" inside cells in the body -- in individuals taking medications to fight the virus. Finally, they are testing the ability of microbicides to prevent sexual transmission of SIV/HIV.

"The monkey disease is a remarkably accurate facsimile of the human disease," said Gardner.

An authority on retroviruses and the intersection of the simian and human immunodeficiency viruses, Gardner will give the keynote address at the conference, highlighting important contributions of nonhuman primate research to knowledge of AIDS.

According to Gardner, some of the key achievements made by researchers studying immunodeficiency viruses in monkeys include: gaining an in-depth knowledge of the natural history of both the human and simian AIDS viruses, including the potential for and mechanisms of cross-species transmission; demonstrating the feasibility of an AIDS vaccine by showing that monkeys became resistant to simian AIDS when injected with weakened versions of the virus; demonstrating that SIV alone, rather than environmental or other factors, causes simian AIDS; defining the mechanisms of HIV/SIV transmission between hosts; and identifying the role of antibodies and cellular immunity, especially CD8 cells -- a specific immune system component -- in fighting the virus.

The symposium traces its origins to 1983, when about 30 researchers from the then seven U.S. primate research centers met at Tulane University to discuss what was then a poorly understood, spontaneously occurring immunodeficiency syndrome of macaque monkeys. The monkey disease had many strong similarities to AIDS, which was first described in 1981. HIV was first identified in 1983 and SIV in 1985.

Gardner said the founders of the primate centers could never have imagined that monkeys, specifically the Asian rhesus macaque, would play such a critical role in fighting the global AIDS pandemic. Over the past 20 years, AIDS has sickened or killed nearly 40 million people. An estimated 68 million people will have died as a result of AIDS by 2020.

Today, more than half of the research done at the federally funded primate research centers is AIDS-related. In fact, directors of the primate centers maintain they are unable to meet the demand for monkeys for AIDS research and other work because of limited resources. The recent focus on bioterrorism research has further strained an already tight supply.

Patricia Bailey | EurekAlert!
Further information:
http://www.ucdavis.edu/

More articles from Health and Medicine:

nachricht Cholesterol-lowering drugs may fight infectious disease
22.08.2017 | Duke University

nachricht Once invincible superbug squashed by 'superteam' of antibiotics
22.08.2017 | University at Buffalo

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Cholesterol-lowering drugs may fight infectious disease

22.08.2017 | Health and Medicine

Meter-sized single-crystal graphene growth becomes possible

22.08.2017 | Materials Sciences

Repairing damaged hearts with self-healing heart cells

22.08.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>